Review
Version 1
This version is not peer-reviewed
SARS-CoV-2 Vaccines: ‘Warp Speed’ Needs Mind Melds not Warped Minds
*
and
Version 1
: Received: 5 June 2020 / Approved: 7 June 2020 / Online: 7 June 2020 (10:26:44 CEST)
Version 2 : Received: 19 June 2020 / Approved: 21 June 2020 / Online: 21 June 2020 (15:44:06 CEST)
Version 2 : Received: 19 June 2020 / Approved: 21 June 2020 / Online: 21 June 2020 (15:44:06 CEST)
How to cite: Moore, J.P.; Klasse, P.J. SARS-CoV-2 Vaccines: ‘Warp Speed’ Needs Mind Melds not Warped Minds. Preprints 2020, 2020060079 Moore, J.P.; Klasse, P.J. SARS-CoV-2 Vaccines: ‘Warp Speed’ Needs Mind Melds not Warped Minds. Preprints 2020, 2020060079
Abstract
In this review, we address issues that relate to the rapid “Warp Speed” development of vaccines to counter the COVID-19 pandemic. We review the antibody response that is triggered by SARS-CoV-2 infection of humans, and how it may inform vaccine research. The isolation and properties of neutralizing monoclonal antibodies from COVID-19 patients provide additional information on what vaccines should try to elicit. The nature and longevity of the antibody response to coronaviruses are relevant to the potency and duration of vaccine-induced immunity. We summarize the immunogenicity of leading vaccine candidates tested to date in animals and humans, and discuss the outcome and interpretation of virus-challenge experiments. By far the most immunogenic vaccine candidates for antibody responses are recombinant proteins, which are not represented in the “Warp Speed” program. A substantial concern for SARS-CoV-2 vaccines is adverse events, which we review by considering what was seen in studies of SARS-CoV-1 and MERS-CoV vaccines. We conclude by outlining the possible outcomes of the “Warp Speed” vaccine program.
Keywords
SARS-CoV-2; COVID-19; neutralizing antibodies; serology; vaccines; animal models
Subject
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
